Cancer Research CTRC-AACR San Antonio Breast Cancer Symposium
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 53, 5096-5099, November 1, 1993]
© 1993 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Gong, J.
Right arrow Articles by Darzynkiewicz, Z.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gong, J.
Right arrow Articles by Darzynkiewicz, Z.

Simultaneous Analysis of Cell Cycle Kinetics at Two Different DNA Ploidy Levels Based on DNA Content and Cyclin B Measurements1

Jianping Gong, Frank Traganos and Zbigniew Darzynkiewicz2

The Cancer Research Institute, New York Medical College, Valhalla, New York 10595

The methods of cell cycle analysis that rely on DNA content measurements cannot discriminate between cells at different phases of the cycle if these cells have similar DNA content. This limitation can be circumvented by measurement of another cell cycle phase-specific cell constituent in addition to DNA content, followed by bivariate analysis of the correlated data. The aim of the present study was to explore the utility of a monoclonal antibody against the G2- and M phase-specific regulatory protein cyclin B for discrimination of cell populations with overlapping DNA content. This analysis, which was based on correlated DNA/cyclin B content measurements by flow cytometry, was applied to human lymphocytic leukemic MOLT-4 cells. The onset of cyclin B synthesis was observed in the last one third of S phase with its maximum accumulation in G2 and M phases; cells in G1 and early- and mid-S phases were negative. Cells arrested in metaphase by vinblastine expressed high levels of this protein, although not as high as in cells arrested in G2 by the DNA topoisomerase II inhibitor m-AMSA. Disruption of cytokinesis by the protein kinase inhibitor staurosporine led to DNA rereplication, cell progression through the chromatin cycle at higher DNA ploidy, and induction of polyploidy. It was possible, utilizing the cyclin B antibody, to discriminate between G2 + M cells with a 2C level of DNA and G1 cells with 4C DNA, as well as to distinguish doublets of G1 cells with a 2C DNA level. Thus, the rate of cell entrance to G1 at the 4C DNA level and the rates of progression through the cycle at both the 2C and 4C DNA levels could be simultaneously estimated. The data indicate that, in the presence of 0.1 µM staurosporine, cytokinesis of all MOLT-4 cells is impaired and the cells enter to and progress through the chromosome cycle at 4C DNA at the same rates as at 2C DNA. This approach can be helpful in the analysis of DNA ploidy and the cell cycle of human tumors when there is an overlap in DNA content values between normal stromal or infiltrating cells and aneuploid tumor cell population and may be the method of choice to investigate the activity of antitumor drugs which impair cytokinesis but do not interfere with progression of cells through the chromatin cycle.

1 This work was supported by the This Close Foundation for Cancer Research and by USPHS Grant RO1 CA 28704, as well as the Carl Inserra Fund.

2 To whom requests for reprints should be addressed, at The Cancer Research Institute, New York Medical College, 100 Grasslands Road, Elmsford, NY 10523.

Received 8/17/93. Accepted 9/20/93.




This article has been cited by other articles:


Home page
Molecular Cancer TherapeuticsHome page
B. A. Narayanan, N. K. Narayanan, L. Davis, and D. Nargi
RNA interference-mediated cyclooxygenase-2 inhibition prevents prostate cancer cell growth and induces differentiation: modulation of neuronal protein synaptophysin, cyclin D1, and androgen receptor
Mol. Cancer Ther., May 1, 2006; 5(5): 1117 - 1125.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Biol.Home page
L. Xu and E. H. Blackburn
Human Rif1 protein binds aberrant telomeres and aligns along anaphase midzone microtubules
J. Cell Biol., December 6, 2004; 167(5): 819 - 830.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
H. Zhu and N. Gooderham
Neoplastic Transformation of Human Lung Fibroblast MRC-5 SV2 Cells Induced by Benzo[a]pyrene and Confluence Culture
Cancer Res., August 15, 2002; 62(16): 4605 - 4609.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
G. Juan and C. Cordon-Cardo
Intranuclear Compartmentalization of Cyclin E during the Cell Cycle: Disruption of the Nucleoplasm-Nucleolar Shuttling of Cyclin E in Bladder Cancer
Cancer Res., February 1, 2001; 61(3): 1220 - 1226.
[Abstract] [Full Text]


Home page
Cancer Res.Home page
H. Zhu, A. R. Boobis, and N. J Gooderham
The Food-derived Carcinogen 2-Amino-1-methyl-6-phenylimidazo[4,5-b]pyridine Activates S-Phase Checkpoint and Apoptosis, and Induces Gene Mutation in Human Lymphoblastoid TK6 Cells
Cancer Res., March 1, 2000; 60(5): 1283 - 1289.
[Abstract] [Full Text]


Home page
Alcohol AlcoholHome page
K. Mashimo, T. Haseba, and Y. Ohno
FLOW CYTOMETRIC AND FLUORESCENCE MICROSCOPIC ANALYSIS OF ETHANOL-INDUCED G2+M BLOCK: ETHANOL DOSE-DEPENDENTLY DELAYS THE PROGRESSION OF THE M PHASE
Alcohol Alcohol., May 1, 1999; 34(3): 300 - 310.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
N. Vitrat, K. Cohen-Solal, C. Pique, J. P. LeCouedic, F. Norol, A. K. Larsen, A. Katz, W. Vainchenker, and N. Debili
Endomitosis of Human Megakaryocytes Are Due to Abortive Mitosis
Blood, May 15, 1998; 91(10): 3711 - 3723.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1993 by the American Association for Cancer Research.